B. Bhardwaj, A. Mahajan, M. Singh, R. Roy, R. Sharma
Rampant, irrational and unscientific use of antimicrobials by the healthcare practitioners is adding to the problem of antimicrobial resistance. Therefore, it is of utmost importance to evolve and implement new policies, recommence research actions and pursue steps to manage the crisis of antimicrobial resistance, which can be accomplished by a well-designed Antimicrobial Stewardship programme. A prospective observational study aiming to investigate the use of antimicrobials in Intensive Care Units by means of an AMS programme was carried out in a 400 bedded tertiary level hospital in New Delhi with 140 ICU beds. This evidence-based study looks
into the prescription and consumption of antimicrobials, specifically in the ICUs, and attempts to corelate it with the resistance pattern of antimicrobials being used. All the patients being treated with antimicrobials, admitted in the ICUs of the hospital were selected for this descriptive research. Information associated with antimicrobials including the susceptibility pattern of isolates and full dosage regime of each patient from the group was obtained by conducting daily audits for a period of five months. Among the usage of different antimicrobial categories (antibacterial, antifungal and antiviral), the resistance percentage correlation was predominantly focused on the
antibacterial. However, the study suggests no conclusive direct or indirect correlation between the usage of an antibacterial (in terms of prescription and consumption) and its resistance, which itself could be a cause of concern for medical practitioners.
Alyssa, R. (2018). Cephalosporins. UpToDate Website: https://www.uptodate.com/contents/cephalosporins
Antibiotic / Antimicrobial Resistance (AR / AMR), Centers for Disease Control and Prevention Website: https://www.cdc.gov/drugresistance/about.html
Antimicrobial Resistance, World Health Organization Website: https://www.who.int/antimicrobial-resistance/en/
Antimicrobial Stewardship: A competency-based approach, World Health Organization Website: https://openwho.org/courses/AMR-competency
ATC/DDD Index 2019, WHO Collaborating Centre for Drug Statistics Methodology Website: http://www.whocc.no/atcddd/
Austin, D. J., Kristinsson, K. G., & Anderson, R. M. (1999). The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proceedings of the National Academy of Sciences, 96(3), 1152–1156. https://doi.org/10.1073/pnas.96.3.1152
Bae, S., Kim, M. C., Park, S. J., Kim, H. S., Sung, H., Kim, M. N., … & Kim, Y. S. (2016). In vitro synergistic activity of antimicrobial agents in combination against clinical isolates of colistin-resistant Acinetobacterbaumannii. Antimicrobial agents and chemotherapy, AAC-00839. https://dx.doi.org/10.1128%2FAAC.00839-16
DDD Indicators, World Health Organization Website: https://www.who.int/medicines/regulation/medicines-safety/toolkit_indicators/en/
Definition and General Considerations, WHO Collaborating Centre for Drug Statistics Methodology Website: www.whocc.no/ddd/definition_and_general_considera/
Griffith, M., Postelnick, M., & Scheetz, M. (2012). Antimicrobial stewardship programs: methods of operation and suggested outcomes. Expert review of
anti-infective therapy, 10(1), 63–73. https://doi.org/10.1586/eri.11.153
Jamshidi, M., Javadpour, S., Eftekhari, T. E., Moradi, N., & Jomehpour, F. (2009). Antimicrobial resistance pattern among intensive care unit patients. African Journal of Microbiology Research, 3(10), 590–594.
Laxminarayan, R., Duse, A., Wattal, C., Zaidi, A. K., Wertheim, H. F., Sumpradit, N., … &Greko, C. (2013). Antibiotic resistance—the need for global solutions. The Lancet infectious diseases, 13(12), 1057–1098.https://doi.org/10.1016/S1473-3099(13)70318-9
Lim, C., Takahashi, E., Hongsuwan, M., Wuthiekanun, V., Thamlikitkul, V., Hinjoy, S., … &Limmathurotsakul,D. (2016). Epidemiology and burden of multidrug-resistant
bacterial infection in a developing country. Elife, 5, e18082. PDF: https://cdn.elifesciences.org/articles/18082/elife-18082-v1.pdf
Marschner, J. P., Thürmann, P., Harder, S., &Rietbrock, N. (1994). Drug utilization review on a surgical intensive care unit. International journal of clinical pharmacology
and therapeutics, 32(9), 447–451. PMID: 7820326
Merzougui, L., Barhoumi, T., Guizani, T., Barhoumi, H., Hannachi, H., Turki, E., &Majdoub, W. (2018). Les infections nosocomialesen milieu de réanimation:
incidence annuelle et aspects cliniques au Service de RéanimationPolyvalente, Kairouan, Tunisie, 2014. The Pan African medical journal, 30. https://dx.doi.org/10.11604%2Fpamj.2018.30.143.13824
Metrics and Evaluation. Public Health Ontario: https://www.publichealthontario.ca/fr/eRepository/ASP%20Metric%20examples.pdf
Penicillins, O. (2000). Appropriate prescribing of oral betalactam antibiotics. Am Fam Physician, 62, 611–620. http://www.p-e-g.de/Research_News/10092000-6.html
Sharma, P. R., & Barman, P. (2010). Antimicrobial consumption and impact of “Reserve antibiotic indent form” in an intensive care unit. Indian journal of pharmacology, 42(5), 297. https://doi.org/10.4103/0253-7613.70216
Spellberg, B., & Gilbert, D. N. (2014). The future of antibiotics and resistance: a tribute to a career of leadership by John Bartlett. Clinical infectious diseases, 59(suppl_2),
S71–S75. https://doi.org/10.1093/cid/ciu392
Sulieman, H., El-Mahdi, W., Awadelkareem, M., &Nazer, L. (2018). Characteristics of Critically-Ill Patients at Two Tertiary Care Hospitals in Sudan. Sultan Qaboos University Medical Journal, 18(2), e190. https://dx.doi.org/10.18295%2Fsqumj.2018.18.02.011
Surveillance of Antimicrobial Use, World Health Organization Website: https://www.who.int/medicines/areas/rational_use/AMU_Surveillance/en/
Toptas, M., SengulSamanci, N., Akkoc, İ., Yucetas, E., Cebeci, E., Sen, O., … & Ozturk, S. (2018). Factors Affecting the Length of Stay in the Intensive Care
Unit: Our Clinical Experience. BioMed research international, 2018. https://dx.doi.org/10.1155%2F2018%2F9438046